S. Holdenrieder

Real-world efficacy and tolerability of lipid-lowering therapy in children with monogenic familial hypercholesterolemia in primary care

LLM can be safely and effectively administered in primary care for children with monogenic FH and already low-dose statins resulted in substantial LDL-C reduction, demonstrating real world applicability of guideline recommendations for early start of treatment in FH in a primary care setting.